Bell Michael Brian, an insider at Guardant Health Inc (GH), sold 29,665 shares of the company's stock on December 14, 2025. The shares were sold at a price of $102.67 each, bringing the total transaction value to $3.05 million. Following this sale, Brian retains 29,665 shares of Guardant Health.
Guardant Health, headquartered in Palo Alto, California, is a precision oncology company focused on cancer treatment through proprietary blood-based tests and advanced analytics. The company, which has a market cap of $12.1 billion, employs 1,999 full-time staff and went public on October 4, 2018.
The upcoming earnings report is scheduled for July 28, 2026, with an estimated EPS of -$0.61 and revenue expectations of $305.5 million. This insider transaction provides insight into the personal financial decisions of executives, though such actions should be viewed alongside broader market factors and multiple insider activities for a more comprehensive analysis.